Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Bockmayr

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Genes, Chromosomes & Cancer|October 24, 2015
Mutations in genes encoding PI3K-AKT and MAPK signaling define anogenital papillary hidradenomaNicole Pfarr, Hans-Peter Sinn, Frederick Klauschen, et al.
Genes, Chromosomes & Cancer|April 24, 2016
Pan-cancer analysis of copy number changes in programmed death-ligand 1 (PD-L1, CD274) - associations with gene expression, mutational load, and survivalJan Budczies, Michael Bockmayr, Carsten Denkert, et al.
Genes, Chromosomes & Cancer|July 21, 2016
Tubular, lactating, and ductal adenomas are devoid of MED12 Exon2 mutations, and ductal adenomas show recurrent mutations in GNAS and the PI3K-AKT pathwayAnna-Lena Volckmar, Jonas Leichsenring, Christa Flechtenmacher, et al.
The Journal of Clinical Investigation|July 1, 2020
Glioma escape signature and clonal development under immune pressureCecile L Maire, Malte Mohme, Michael Bockmayr, et al.
Acta Neuropathologica|March 5, 2019
TCF4 (E2-2) harbors tumor suppressive functions in SHH medulloblastomaMalte Hellwig, Marlen C Lauffer, Michael Bockmayr, et al.
Oncoimmunology|April 14, 2017
PD-L1 (CD274) copy number gain, expression, and immune cell infiltration as candidate predictors for response to immune checkpoint inhibitors in soft-tissue sarcomaJan Budczies, Gunhild Mechtersheimer, Carsten Denkert, et al.
Neuro-Oncology|March 3, 2023
Atypical neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entitiesCatena Kresbach, Matthias Dottermusch, Alicia Eckhardt, et al.
Neuro-Oncology Advances|December 23, 2024
Impact of molecular classification on prognosis in children and adolescents with spinal ependymoma: Results from the HIT-MED databaseLara Engertsberger, Martin Benesch, Martin Mynarek, et al.
Acta Neuropathologica|July 14, 2023
Recurrent atypical teratoid/rhabdoid tumors (AT/RT) reveal discrete features of progression on histology, epigenetics, copy number profiling, and transcriptomicsPascal D Johann, Lea Altendorf, Emma-Maria Efremova, et al.
Blood Advances|October 11, 2018
Combined inhibition of receptor tyrosine and p21-activated kinases as a therapeutic strategy in childhood ALLIna-Katrin Siekmann, Kevin Dierck, Sebastian Prall, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Genes, Chromosomes & Cancer|October 24, 2015
Mutations in genes encoding PI3K-AKT and MAPK signaling define anogenital papillary hidradenomaNicole Pfarr, Hans-Peter Sinn, Frederick Klauschen, et al.
Genes, Chromosomes & Cancer|April 24, 2016
Pan-cancer analysis of copy number changes in programmed death-ligand 1 (PD-L1, CD274) - associations with gene expression, mutational load, and survivalJan Budczies, Michael Bockmayr, Carsten Denkert, et al.
Genes, Chromosomes & Cancer|July 21, 2016
Tubular, lactating, and ductal adenomas are devoid of MED12 Exon2 mutations, and ductal adenomas show recurrent mutations in GNAS and the PI3K-AKT pathwayAnna-Lena Volckmar, Jonas Leichsenring, Christa Flechtenmacher, et al.
The Journal of Clinical Investigation|July 1, 2020
Glioma escape signature and clonal development under immune pressureCecile L Maire, Malte Mohme, Michael Bockmayr, et al.
Acta Neuropathologica|March 5, 2019
TCF4 (E2-2) harbors tumor suppressive functions in SHH medulloblastomaMalte Hellwig, Marlen C Lauffer, Michael Bockmayr, et al.
Oncoimmunology|April 14, 2017
PD-L1 (CD274) copy number gain, expression, and immune cell infiltration as candidate predictors for response to immune checkpoint inhibitors in soft-tissue sarcomaJan Budczies, Gunhild Mechtersheimer, Carsten Denkert, et al.
Neuro-Oncology|March 3, 2023
Atypical neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entitiesCatena Kresbach, Matthias Dottermusch, Alicia Eckhardt, et al.
Neuro-Oncology Advances|December 23, 2024
Impact of molecular classification on prognosis in children and adolescents with spinal ependymoma: Results from the HIT-MED databaseLara Engertsberger, Martin Benesch, Martin Mynarek, et al.
Acta Neuropathologica|July 14, 2023
Recurrent atypical teratoid/rhabdoid tumors (AT/RT) reveal discrete features of progression on histology, epigenetics, copy number profiling, and transcriptomicsPascal D Johann, Lea Altendorf, Emma-Maria Efremova, et al.
Blood Advances|October 11, 2018
Combined inhibition of receptor tyrosine and p21-activated kinases as a therapeutic strategy in childhood ALLIna-Katrin Siekmann, Kevin Dierck, Sebastian Prall, et al.
Pageof 6